GlassScriptPhysician profile
Christina Wheelock
NPI 1477442283
$1,223.81
in general payments reported to CMS, 2019-2025
20 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $180.88 | 2025 | Xcopri |
| Janssen Biotech, INC. | $162.08 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $150.76 | 2025 | Rexulti |
| Abbvie INC. | $139.41 | 2025 | |
| Lilly USA, LLC | $97.33 | 2025 | Kisunla, Zepbound |
| Argenx US, INC. | $65.92 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Livanova USA, INC. | $52.94 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $47.23 | 2025 | |
| Lundbeck LLC | $41.81 | 2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $33.45 | 2025 | |
| Averitas Pharma INC. | $32.52 | 2025 | Qutenza |
| Harmony Biosciences LLC | $30.50 | 2025 | |
| Biogen, INC. | $29.44 | 2025 | Vumerity |
| Neurocrine Biosciences, INC. | $26.24 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $25.30 | 2025 | Austedo Xr |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $25.26 | 2025 | Acthar |
| Axsome Therapeutics, INC. | $24.00 | 2025 | Symbravo |
| Emd Serono, INC. | $21.32 | 2025 | |
| Amneal Pharmaceuticals LLC | $20.63 | 2025 | Crexont |
| Neurelis, INC. | $16.79 | 2025 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Wheelock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.